High Outlier
Strength
6 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834013660
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
11/20/2019
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203844On Market Since
9/4/2017
Pharmacological Classes
Cholinesterase Inhibitor
Cholinesterase Inhibitors
Related Drugs
Same classification
DONEPEZIL HCL 5 MG TABLET
Generic
00904647761•Major Pharmaceuticals
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010210•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010230•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010290•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077803•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077809•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077810•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077850•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
31722073705•Camber Pharmaceuticals Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
31722073730•Camber Pharmaceuticals Inc.
$0.0440
per EA